The Asia Pacific Endometriosis Market would witness market growth of 12.5% CAGR during the forecast period (2022-2028).
Treatments exist that can lessen the disease's progression and improve symptoms. Treatments include painkillers like hormone supplements, ibuprofen, and paracetamol, and contraceptives, surgery to remove endometriosis tissue patches by cutting them out or by lasering (vaporizing) them, and an operation to remove all or some of the damaged organs.
The inability to conceive is one of the main effects of endometriosis. The patient might never be able to become pregnant (infertility). Having endometriosis surgically removed can increase a woman's chances of becoming pregnant. However, there is no assurance that they will be able to conceive after treatment. Endometriosis surgery could result in further complications. For instance, organ damage, hemorrhage, or infections. If surgery is advised, discuss the potential risks with the surgeon.
Due to a lack of menstrual awareness, restricted access to sanitary products, and a hostile school environment, girls may find it challenging to attend class. India's government and non-governmental organizations have created programs to minimize the difficulty of schoolgirls' menstruation (NGOs). This sought to identify barriers to menstruation management in schools and facilitators in three Indian states. The Indian government has established several programs to improve menstrual hygiene management (MHM) in schools, with assistance from a number of organizations, with the goal of enhancing knowledge about feminine hygiene and related diseases. It also plays a significant role in raising awareness among women regarding menstrual hygiene, well-being, and educational achievements. Women in this region experience a variety of menstrual issues, which inspires them to use femtech apps for efficient care. This will spur market expansion in the Asia Pacific region.
The China market dominated the Asia Pacific Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $177.3 million by 2028. The Japan market is estimated to grow a CAGR of 11.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 13.2% during (2022 - 2028).
Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Endometriosis Market is Projected to reach USD 2.2 Billion by 2028, at a CAGR of 11.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
By Type
By Treatment
By Distribution Channel
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
